Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.1B | 2.3B | 2.1B | 2.2B |
Cost of revenue | 1.3B | 1.4B | 1.3B | 1.4B |
Gross profit | 768M | 857M | 784M | 819M |
Operating expense | ||||
Research & development | 56M | 58M | 55M | 58M |
Selling general and admin | 460M | 507M | 445M | 485M |
Other operating expenses | — | — | — | — |
Operating income | 252M | 292M | 284M | 276M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 8M | 9M | 10M | 11M |
Other income expense | -27M | 64M | -5M | -18M |
Pretax income | 217M | 375M | 269M | 247M |
Tax provision | 50M | 49M | 52M | 53M |
Net income | 167M | 326M | 217M | 194M |
Basic EPS | 0.7 | — | 0.9 | 0.8 |
Diluted EPS | 0.7 | — | 0.9 | 0.8 |
Basic average shares | 243.1M | — | 242.9M | 242.6M |
Diluted average shares | 243.8M | — | 243.8M | 243.5M |
EBITDA | 401M | 591M | 426M | 425M |
Net income from continuing op. | 169M | 326M | 217M | 194M |
Minority interests | 2M | — | — | — |
Preferred stock dividends | — | — | — | — |